MCM
CBST

Matarin Capital Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Matarin Capital Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-3,746
Closed -$181K – 235
2013
Q2 		$181K Buy
+3,746
New +$184K 0.18% 166

Other funds holding CBST

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Matarin Capital Management's CBST Position: Q3 2013 in Review

Matarin Capital Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q3 2013, closing a stake of 3,746 shares — an estimated $181K sold.

Matarin Capital Management first reported a position in CBST in Q2 2013 and held it in 1 quarter. The position peaked at $181K in Q2 2013. 271 funds tracked by Wall St. Rank hold CBST as of Q3 2013.

  • Matarin Capital Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q3 2013 after selling out during the quarter.
  • Matarin Capital Management sold 3,746 CUBIST PHARMACEUTICALS INC shares in Q3 2013, an estimated $181K.
  • Matarin Capital Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 1 quarter.
  • Matarin Capital Management's CUBIST PHARMACEUTICALS INC position peaked at $181K in Q2 2013.
  • 271 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q3 2013.

Based on Matarin Capital Management's 13F filing for Q3 2013, filed 30 Oct 2013.